The Drugs Controller General of India (DCGI) approved the commercial launch of ‘Feluda’, the Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Covid-19 test on Saturday. The new test - Feluda, named after the fictional detective character created by renowned filmmaker and writer Satyajit Ray is said to be easy to use, provides faster results and at a much lower cost than existing Covid tests such as the RT-PCR.
We try to find out how this test works and what it means for India’s testing capacity. What is the technology behind this test? This ...
TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST Rs
Key stories on business-standard.com are available to premium subscribers only.
RECOMMENDED FOR YOU